pemetrexed disodium · Hospira · NDA 214218, 214408, 214657
Pemetrexed Disodium
Earliest generic entry, as listed · earliest of 6 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 10
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 214218 · 001 · RLD | solution, intravenous | EQ 100MG BASE/4ML (EQ 25MG BASE/ML) | open |
| 214218 · 002 · RLD | solution, intravenous | EQ 500MG BASE/20ML (EQ 25MG BASE/ML) | open |
| 214218 · 003 · RLD | solution, intravenous | EQ 1GM BASE/40ML (EQ 25MG BASE/ML) | open |
| 214408 · 001 · RLD · discontinued | solution, intravenous | EQ 100MG BASE/4ML (EQ 25MG BASE/ML) | open |
| 214408 · 002 · RLD · discontinued | solution, intravenous | EQ 500MG BASE/20ML (EQ 25MG BASE/ML) | open |
| 214408 · 003 · RLD · discontinued | solution, intravenous | EQ 850MG BASE/34ML (EQ 25MG BASE/ML) | open |
| 214408 · 004 · RLD · discontinued | solution, intravenous | EQ 1GM BASE/40ML (EQ 25MG BASE/ML) | open |
| 214657 · 001 · RLD | solution, intravenous | EQ 100MG BASE/4ML (EQ 25MG BASE/ML) | open |
| 214657 · 002 · RLD | solution, intravenous | EQ 500MG BASE/20ML (EQ 25MG BASE/ML) | open |
| 214657 · 003 · RLD | solution, intravenous | EQ 1GM BASE/40ML (EQ 25MG BASE/ML) | open |